Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells

Gynecologic Oncology

Volumn 108, Issue 3, 2008, Pages 632-640

  Woods, Dori C ^a   Alvarez, Claudia ^a   Johnson, A L ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Apoptosis; Cisplatin; Granulosa cell tumors; p53; TRAIL

Indexed keywords

CASPASE 8; CISPLATIN; FLICE INHIBITORY PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN P53; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ARTICLE; CELL DEATH; CELL VIABILITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GRANULOSA CELL TUMOR; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 39249083670     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.11.034     Document Type: Article

References (32)

1. Colombo N., Parma G., Zanagnolo V., and Insinga A. Management of ovarian stromal cell tumors. J Clin Oncol 25 (2007) 2944-2951
2. Cuello M., Ettenberg S.A., Nau M.M., and Lipkowitz S. Synergistic induction of apoptosis by the combination of TRAIL and chemotherapy in chemoresistant ovarian cancer cells. Gynecol Oncol 81 (2001) 380-390
3. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3 (1995) 673-682
4. Walczak H., Miller R.E., Ariail K., Gliniak B., Griffith T.S., Kubin M., et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5 (1999) 157-163
5. Roth W., Isenmann S., Naumann U., Kugler S., Bahr M., Dichgans J., et al. Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys 265 (1999) 479-483
6. Johnson A.L., Ratajczak C., Haugen M.J., Liu H.K., and Woods D.C. Tumor necrosis factor related apoptosis inducing ligand (TRAIL) expression and activity in hen granulosa cells. Reproduction 133 (2007) 609-613
7. Pan G., O'Rourke K., Chinnaiyan A.M., Gentz R., Ebner R., Ni J., et al. The receptor for the cytotoxic ligand TRAIL. Science 276 (1997) 111-113
8. Pan G., Ni J., Wei Y.F., Yu G., Gentz R., and Dixit V.M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277 (1997) 815-818
9. Sheridan J.P., Marsters S.A., Pitti R.M., Gurney A., Skubatch M., Baldwin D., et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277 (1997) 818-821
10. Schneider P., Thome M., Burns K., Bodmer J.L., Hofmann K., Kataoka T., et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 7 (1997) 831-836
11. Chaudhary P.M., Eby M., Jasmin A., Bookwalter A., Murray J., and Hood L. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity 7 (1997) 821-830
12. Bodmer J.L., Holler N., Reynard S., Vinciguerra P., Schneider P., Juo P., et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2 (2000) 241-243
13. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 (2001) 487-501
14. Johnson A.L., and Bridgham J.T. Caspase-mediated apoptosis in the vertebrate ovary. Reproduction 124 (2002) 19-27
15. El-Diery W.S. Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling. Cell Death Differ 8 (2001) 1066-1075
16. Tsai W.S., Yeow W.S., Chua A., Reddy R.M., Nguyen D.M., Schrump D.S., et al. Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatin. Mol Cancer Ther 5 (2006) 2977-2990
17. Zhang H., Vollmer M., De Geyter M., Litzistorf Y., Ladewig A., Durrenberger M., et al. Characterization of an immortalized human granulosa cell line. Mol Hum Reprod 6 (2000) 146-153
18. Nishi Y., Yanase T., Mu Y., Oba K., Ichino I., Saito M., et al. Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 142 (2001) 437-445
19. Hollstein M., Sidransky D., Vogelstein B., and Harris C.C. p53 mutations in human cancers. Science 253 (1991) 49-53
20. Khan Z.A.J., Jonas S.K., Le-Marer N., Patel H., Wharton R.Q., Tarragona A., et al. p53 mutations in primary and metastatic tumors and circulating tumor cells from colorectal carcinoma patients. Clin Cancer Res 6 (2000) 3499-3504
21. Woods DC, Liu H-K, Nishi Y, Yanase T, Johnson AL. Inhibition of proteosome activity sensitizes human granulosa tumor cells to TRAIL-induced cell death. Cancer Lett in press. doi:10.1016/j.canlet.2007.10.016.
22. -ΔΔCt method. Methods 25 (2001) 402-408
23. Boyd S.D., Tsai K.Y., and Jacks T. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat Cell Biol 9 (2000) 563-568
24. Niikura Y., Nonaka T., and Imajoh-Ohmi S. Monitoring of caspase-8/FLICE processing and activation upon Fas stimulation with novel antibodies directed against a cleavage site for caspase-8 and its substrate, FLICE-Like Inhibitory Protein (FLIP). J Biochem (Tokyo) 132 (2002) 53-62
25. Inoue N., Manabe N., Matsui T., Maeda A., Nakagawa S., Wada S., et al. Roles of tumor necrosis factor-related apoptosis-inducing ligand signaling pathway in granulosa cell apoptosis during atresia in pig ovaries. J Reprod Dev 49 (2003) 313-321
26. Krieg A., Krieg T., Wenzel M., Schmitt M., Ramp U., Fang B., et al. TRAIL-beta and TRAIL-gamma: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential. Br J Cancer 88 (2003) 918-927
27. Nguyen D.M., Yeow W.S., Ziauddin M.F., Baras A., Tsai W., Reddy R.M., et al. The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death. Cancer J 12 (2006) 257-273
28. Petros A.M., Gunasekera A., Xu N., Olejniczak E.T., and Fesik S.W. Defining the p53 DNA-binding domain/Bclx-(L)-binding surface interface using NMR. FEBS Lett 559 (2004) 171-174
29. Cummings B.S., and Schnellmann R.G. Cisplatin-induced renal cell apoptosis: caspase-3 dependent and -independent pathways. J Pharmacol Exp Ther 302 (2002) 8-17
30. Henry H., Thomas A., Shen Y., and White E. Regulation of the mitochondrial checkpoint in p53-mediated apoptosis confers resistance to cell death. Oncogene 21 (2002) 748-760
31. Miyashita T., and Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 (1995) 293-299
32. Liu J., Yin S., Reddy N., Spencer C., and Sheng S. Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res 64 (2004) 1703-1711